Braidwell »

Encompass Health Corp shares owned by Braidwell

Quarter-by-quarter ownership of Encompass Health Corp (EHC) shares owned by Braidwell from 13F filings

Historical chart of Braidwell investment in Encompass Health Corp

Tip: Access up to 7 years of quarterly data

All positions including Encompass Health Corp held by Braidwell consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Encompass Health Corp by Braidwell

Quarter filed Position value Share count Share price at filing
2025-09-30 $14M 113k 127.02

More positions owned by Braidwell

Guardant Health Debt 1.250% 2/1 (Principal)
Caris Life Sciences (CAI)
Novocure Note 11/0 (Principal)
Xenon Pharmaceuticals (XENE)
Cg Oncology (CGON)
Neurocrine Biosciences (NBIX)
Repligen Corp Note 1.000%12/1 (Principal)
Krystal Biotech (KRYS)
Nuvalent Inc-a (NUVL)
Neogenomics Note 0.250% 1/1 (Principal)
Soleno Therapeutics (SLNO)
Irhythm Technologies Note 1.500% 9/0 (Principal)
Edgewise Therapeutics (EWTX)
Ironwood Pharmaceuticals Note 1.500% 6/1 (Principal)
Inspire Med Sys (INSP)

View all positions for Braidwell

Top funds holding Encompass Health Corp

Vanguard Group
BlackRock
Invesco
State Street Corporation
Wellington Management Company
Alliancebernstein
T. Rowe Price Investment Management
Hanna Zanoni
Geode Capital Management
Dimensional Fund Advisors
Raymond James Financial
Jpmorgan Chase & Co
Millennium Management
Thrivent Financial for Lutherans
Franklin Resources

View all funds holding Encompass Health Corp